Amyotrophic lateral sclerosis (ALS) and other motor neuron diseases (MNDs) are major global causes of death. However, their global incidence ...

The experimental therapy M102 slowed disease progression in preclinical experiments done in mouse and cell models of ALS, a ...

A strategic focus on collaboration between industry and academia is essential for sustaining growth and competitiveness in the pharma sector ...

The ALS Association is the world's leading funder of amyotrophic lateral sclerosis (ALS) research -- -- The Hoffman ALS ...

A neuromuscular medicine expert and leader in the field of amyotrophic lateral sclerosis (ALS), Jinsy A. Andrews, MD, joins NYU Langone Health's Department of Neurology to lead its ALS Center, which ...

Kelsie and Chris Snow met in their early 20s when they were sports writers for the Boston Globe in Chris’s hometown. Chris ...

Researchers in Germany say combining two blood biomarkers may make the diagnosis of ALS more accurate and help predict disease progression.

J&J is also running mid-stage trials of a tau active immunotherapy codenamed JNJ-2056 for Alzheimer's, while other active tau ...

Shares surged as investors reacted to a large equity offering combined with renewed optimism around Pasithea’s expanding ...

A drug candidate found to protect nerve cells damaged by motor neuron disease (MND), could offer new hope to people living ...

ALS is a deadly disease that has no known cause, and no cure. But former RJ Sapna, who has been documenting her ...

Scientists have discovered new genes behind Lou Gehrig's disease, bringing them one step closer to understanding the cause of the condition and several other devastating motor neuron diseases. Lou ...